Polyphenols and Cardiovascular disease: A critical summary of the evidence

Mini-Reviews in Medicinal Chemistry

Volumn 11, Issue 14, 2011, Pages 1186-1190

  Visioli, F ^a   Davalos, A ^a  

^a IMDEA FOOD INSTITUTE   (Spain)

Author keywords

Biomarkers; Cardiovascular disease; MicroRNAs; Polyphenols

Indexed keywords

BIOLOGICAL MARKER; FAT; FLAVONOID; MICRORNA; POLYPHENOL DERIVATIVE; SMALL INTERFERING RNA;

3' UNTRANSLATED REGION; ANTIOXIDANT ACTIVITY; BIOAVAILABILITY; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIET SUPPLEMENTATION; DRUG RESEARCH; EVIDENCE BASED MEDICINE; GENE EXPRESSION REGULATION; GENE TARGETING; HEART PROTECTION; HEAT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTESTINE FLORA; LIPID METABOLISM; NUTRITIONAL ASSESSMENT; NUTRITIONAL HEALTH; NUTRITIONAL REQUIREMENT; NUTRITIONAL TOLERANCE; PHYTOCHEMISTRY; REVIEW; RISK REDUCTION; SYNTHESIS; ULTRAVIOLET RADIATION;

EID: 82955214628     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/13895575111091186     Document Type: Review

References (72)

1. Nobili, S.; Lippi, D.; Witort, E.; Donnini, M.; Bausi, L.; Mini, E.;Capaccioli, S. Natural compounds for cancer treatment andprevention. Pharmacol. Res., 2009, 59, 365-378.
2. Chong, M.F.; Macdonald, R.; Lovegrove, J.A. Fruit polyphenolsand CVD risk: a review of human intervention studies. Br. J. Nutr., 2010, 104 Suppl 3, S28-S39.
3. Soerjomataram, I.; Oomen, D.; Lemmens, V.; Oenema, A.;Benetou, V.; Trichopoulou, A.; Coebergh, J.W.; Barendregt, J.; de Vries, E. Increased consumption of fruit and vegetables and futurecancer incidence in selected European countries. Eur. J. Cancer, 2010, 46, 2563-2580.
4. Balsano, C.; Alisi, A. Antioxidant effects of natural bioactivecompounds. Curr. Pharm. Des., 2009, 15, 3063-3073.
5. Bruckert, E.; Rosenbaum, D. Lowering LDL-cholesterol throughdiet: potential role in the statin era. Curr. Opin. Lipidol., 2011, 22, 43-48.
6. Kang, J.; Badger, T.M.; Ronis, M.J.; Wu, X. Non-isoflavonephytochemicals in soy and their health effects. J. Agric. FoodChem., 2010, 58, 8119-8133.
7. Shafiq, N.; Singh, M.; Kaur, S.; Khosla, P.; Malhotra, S. Dietarytreatment for familial hypercholesterolaemia. Cochrane. Database. Syst. Rev., 2010, CD001918.
8. Santo, A.S.; Santo, A.M.; Browne, R.W.; Burton, H.; Leddy, J.J.;Horvath, S.M.; Horvath, P.J. Postprandial lipemia detects the effectof soy protein on cardiovascular disease risk compared with thefasting lipid profile. Lipids, 2010, 45, 1127-1138.
9. Ignarro, L.J.; Balestrieri, M.L.; Napoli, C. Nutrition, physicalactivity, and cardiovascular disease: an update. Cardiovasc. Res., 2007, 73, 326-340.
10. Kapil, V.; Webb, A.J.; Ahluwalia, A. Inorganic nitrate and thecardiovascular system. Heart, 2010, 96, 1703-1709.
11. Iriti, M.; Varoni, E.M.; Vitalini, S. Melatonin in traditionalMediterranean diets. J. Pineal Res., 2010, 49, 101-105.
12. Iriti, M.; Faoro, F. Plant Defense & Human Nutrition:Phenylpropanoids on the Menu. Curr. Topics Nutr. Res., 2004, 2, 47-65.
13. Visioli, F.; Poli, A.; Paoletti, R. Nutritional intervention helpspharmacology in the management of the metabolic syndrome. Med.J. Nutr. Metab., 2010, 3, 203-207.
14. Georgiou, N.A.; Garssen, J.; Witkamp, R.F. Pharma-nutritioninterface: the gap is narrowing. Eur. J. Pharmacol., 2011, 651, 1-8.
15. Dai, J.; Mumper, R.J. Plant phenolics: extraction, analysis and theirantioxidant and anticancer properties. Molecules., 2010, 15, 7313-7352.
16. Buer, C.S.; Imin, N.; Djordjevic, M.A. Flavonoids: new roles forold molecules. J. Integr. Plant Biol., 2010, 52, 98-111.
17. Toguri, T.; Umemoto, N.; Kobayashi, O.; Ohtani, T. Activation ofanthocyanin synthesis genes by white light in eggplant hypocotyltissues, and identification of an inducible P-450 cDNA. Plant Mol. Biol., 1993, 23, 933-946.
18. Visioli, F.; Borsani, L.; Galli, C. Diet and prevention of coronaryheart disease: the potential role of phytochemicals. Cardiovasc. Res., 2000, 47, 419-425.
19. Llorach, R.; Urpi-Sarda, M.; Jauregui, O.; Monagas, M.; Andres-Lacueva, C. An LC-MS-based metabolomics approach forexploring urinary metabolome modifications after cocoaconsumption. J. Proteome Res., 2009, 8, 5060-5068.
20. Pauling, L. Orthomolecular psychiatry. Varying the concentrations of substances normally present in the human body may controlmental disease. Science, 1968, 160, 265-271.
21. Lotito, S.B.; Frei, B. Consumption of flavonoid-rich foods andincreased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon? Free Radic. Biol. Med., 2006, 41, 1727-1746.
22. Gutteridge, J.M.; Halliwell, B. Antioxidants: Molecules, medicines, and myths. Biochem. Biophys. Res. Commun., 2010, 393, 561-564.
23. Halliwell, B. Free radicals and antioxidants-quo vadis? TrendsPharmacol. Sci., 2011.
24. Pecorari, M.; Villano, D.; Testa, M.F.; Schmid, M.; Serafini, M. Biomarkers of antioxidant status following ingestion of green teasat different polyphenol concentrations and antioxidant capacity inhuman volunteers. Mol. Nutr. Food Res., 2010, 54 Suppl 2, S278-S283.
25. Calder, P.C.; Albers, R.; Antoine, J.M.; Blum, S.; Bourdet-Sicard, R.; Ferns, G.A.; Folkerts, G.; Friedmann, P.S.; Frost, G.S.;Guarner, F.; Lovik, M.; Macfarlane, S.; Meyer, P.D.; M'Rabet, L.;Serafini, M.; van Eden, W.; van Loo, J.; Vas, D.W.; Vidry, S.;Winklhofer-Roob, B.M.; Zhao, J. Inflammatory disease processesand interactions with nutrition. Br. J. Nutr., 2009, 101 Suppl 1, S1-45.
26. Visioli, F.; Poli, A.; Richard, D.; Paoletti, R. Modulation ofinflammation by nutritional interventions. Curr. Atheroscler. Rep., 2008, 10, 451-453.
27. Richard, D.; Wolf, C.; Barbe, U.; Kefi, K.; Bausero, P.; Visioli, F. Docosahexaenoic acid down-regulates endothelial Nox 4 through asPLA2 signalling pathway. Biochem. Biophys. Res. Commun., 2009, 389, 516-522.
28. Miller, A.M.; McInnes, I.B. Cytokines as Therapeutic Targets toReduce Cardiovascular Risk in Chronic Inflammation. Curr. Pharm. Des., 2011.
29. Castilla, P.; Echarri, R.; Davalos, A.; Cerrato, F.; Ortega, H.;Teruel, J.L.; Lucas, M.F.; Gomez-Coronado, D.; Ortuno, J.;Lasuncion, M.A. Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysispatients and healthy subjects. Am. J. Clin. Nutr., 2006, 84, 252-262.
30. Davalos, A.; Fernandez-Hernando, C.; Cerrato, F.; Martinez-Botas, J.; Gomez-Coronado, D.; Gomez-Cordoves, C.; Lasuncion, M.A. Red grape juice polyphenols alter cholesterol homeostasis andincrease LDL-receptor activity in human cells in vitro. J. Nutr., 2006, 136, 1766-1773.
31. Quigley, E.M. Prebiotics and probiotics; modifying and mining themicrobiota. Pharmacol. Res., 2010, 61, 213-218.
32. Laparra, J.M.; Sanz, Y. Interactions of gut microbiota withfunctional food components and nutraceuticals. Pharmacol. Res., 2010, 61, 219-225.
33. Parkar, S.G.; Stevenson, D.E.; Skinner, M.A. The potentialinfluence of fruit polyphenols on colonic microflora and human guthealth. Int. J. Food Microbiol., 2008, 124, 295-298.
34. Eussen, S.R.; Rompelberg, C.J.; Andersson, K.E.; Klungel, O.H.;Hellstrand, P.; Oste, R.; van Kranen, H.; Garssen, J. Simultaneousintake of oat bran and atorvastatin reduces their efficacy to lowerlipid levels and atherosclerosis in LDLr-/-mice. Pharmacol. Res., 2011.
35. Morand, C.; Dubray, C.; Milenkovic, D.; Lioger, D.; Martin, J.F.;Scalbert, A.; Mazur, A. Hesperidin contributes to the vascularprotective effects of orange juice: a randomized crossover study inhealthy volunteers. Am. J. Clin. Nutr., 2011, 93, 73-80.
36. Rusconi, M.; Conti, A. Theobroma cacao L., the Food of the Gods:a scientific approach beyond myths and claims. Pharmacol. Res., 2010, 61, 5-13.
37. Grassi, D.; Desideri, G.; Croce, G.; Tiberti, S.; Aggio, A.; Ferri, C. Flavonoids, vascular function and cardiovascular protection. Curr. Pharm. Des., 2009, 15, 1072-1084.
38. Covas, M.I. Olive oil and the cardiovascular system. Pharmacol. Res., 2007, 55, 175-186.
39. Mattick, J.S. Non-coding RNAs: the architects of eukaryoticcomplexity. EMBO Rep., 2001, 2, 986-991.
40. Lander, E.S. Initial impact of the sequencing of the human genome. Nature, 2011, 470, 187-197.
41. Taft, R.J.; Pang, K.C.; Mercer, T.R.; Dinger, M.; Mattick, J.S. NoncodingRNAs: regulators of disease. J. Pathol., 2010, 220, 126-139.
42. Bartel, D.P. MicroRNAs: target recognition and regulatoryfunctions. Cell, 2009, 136, 215-233.
43. Vasudevan, S.; Tong, Y.; Steitz, J.A. Switching from repression toactivation: microRNAs can up-regulate translation. Science, 2007, 318, 1931-1934.
44. Lee, E.K.; Gorospe, M. Coding region: The neglected posttranscriptionalcode. RNA. Biol, 2011, 8.
45. Liu, N.; Olson, E.N. MicroRNA regulatory networks incardiovascular development. Dev. Cell, 2010, 18, 510-525.
46. Small, E.M.; Olson, E.N. Pervasive roles of microRNAs incardiovascular biology. Nature, 2011, 469, 336-342.
47. Wen, X.Y.; Wu, S.Y.; Li, Z.Q.; Liu, Z.Q.; Zhang, J.J.; Wang, G.F.;Jiang, Z.H.; Wu, S.G. Ellagitannin (BJA3121), an anti-proliferativenatural polyphenol compound, can regulate the expression ofMiRNAs in HepG2 cancer cells. Phytother. Res., 2009, 23, 778-784.
48. Tsang, W.P.; Kwok, T.T. Epigallocatechin gallate up-regulation ofmiR-16 and induction of apoptosis in human cancer cells. J. Nutr. Biochem., 2010, 21, 140-146.
49. Fix, L.N.; Shah, M.; Efferth, T.; Farwell, M.A.; Zhang, B. MicroRNA expression profile of MCF-7 human breast cancer cellsand the effect of green tea polyphenon-60. Cancer GenomicsProteomics., 2010, 7, 261-277.
50. Sun, Q.; Cong, R.; Yan, H.; Gu, H.; Zeng, Y.; Liu, N.; Chen, J.;Wang, B. Genistein inhibits growth of human uveal melanomacells and affects microRNA-27a and target gene expression. Oncol. Rep., 2009, 22, 563-567.
51. Murase, T.; Misawa, K.; Minegishi, Y.; Aoki, M.; Ominami, H.;Suzuki, Y.; Shibuya, Y.; Hase, T. Coffee polyphenols suppressdiet-induced body fat accumulation by downregulating SREBP-1cand related molecules in C57BL/6J mice. Am. J. Physiol. Endocrinol. Metab., 2011, 300, E122-E133.
52. Tili, E.; Michaille, J.J.; Adair, B.; Alder, H.; Limagne, E.; Taccioli, C.; Ferracin, M.; Delmas, D.; Latruffe, N.; Croce, C.M. Resveratroldecreases the levels of miR-155 by upregulating miR-663, amicroRNA targeting JunB and JunD. Carcinogenesis, 2010, 31, 1561-1566.
53. Tili, E.; Michaille, J.J.; Alder, H.; Volinia, S.; Delmas, D.; Latruffe, N.; Croce, C.M. Resveratrol modulates the levels of microRNAstargeting genes encoding tumor-suppressors and effectors ofTGFbeta signaling pathway in SW480 cells. Biochem. Pharmacol., 2010, 80, 2057-2065.
54. Mukhopadhyay, P.; Mukherjee, S.; Ahsan, K.; Bagchi, A.; Pacher, P.; Das, D.K. Restoration of altered microRNA expression in theischemic heart with resveratrol. PLoS One., 2010, 5, e15705.
55. Chen, X.; Ba, Y.; Ma, L.; Cai, X.; Yin, Y.; Wang, K.; Guo, J.;Zhang, Y.; Chen, J.; Guo, X.; Li, Q.; Li, X.; Wang, W.; Zhang, Y.;Wang, J.; Jiang, X.; Xiang, Y.; Xu, C.; Zheng, P.; Zhang, J.; Li, R.;Zhang, H.; Shang, X.; Gong, T.; Ning, G.; Wang, J.; Zen, K.;Zhang, J.; Zhang, C.Y. Characterization of microRNAs in serum: anovel class of biomarkers for diagnosis of cancer and otherdiseases. Cell Res., 2008, 18, 997-1006.
56. Weber, J.A.; Baxter, D.H.; Zhang, S.; Huang, D.Y.; Huang, K.H.;Lee, M.J.; Galas, D.J.; Wang, K. The microRNA spectrum in 12body fluids. Clin. Chem., 2010, 56, 1733-1741.
57. Adachi, T.; Nakanishi, M.; Otsuka, Y.; Nishimura, K.; Hirokawa, G.; Goto, Y.; Nonogi, H.; Iwai, N. Plasma microRNA 499 as abiomarker of acute myocardial infarction. Clin. Chem., 2010, 56, 1183-1185.
58. D'Alessandra, Y.; Devanna, P.; Limana, F.; Straino, S.; Di Carlo, A.; Brambilla, P.G.; Rubino, M.; Carena, M.C.; Spazzafumo, L.;De Simone, M.; Micheli, B.; Biglioli, P.; Achilli, F.; Martelli, F.;Maggiolini, S.; Marenzi, G.; Pompilio, G.; Capogrossi, M.C. Circulating microRNAs are new and sensitive biomarkers ofmyocardial infarction. Eur. Heart J., 2010, 31, 2765-2773.
59. Frost, R.J.; van Rooij, E. miRNAs as therapeutic targets inischemic heart disease. J. Cardiovasc. Transl. Res., 2010, 3, 280-289.
60. Fichtlscherer, S.; De Rosa, S.; Fox, H.; Schwietz, T.; Fischer, A.;Liebetrau, C.; Weber, M.; Hamm, C.W.; Roxe, T.; Muller-Ardogan, M.; Bonauer, A.; Zeiher, A.M.; Dimmeler, S. CirculatingmicroRNAs in patients with coronary artery disease. Circ. Res., 2010, 107, 677-684.
61. Zampetaki, A.; Kiechl, S.; Drozdov, I.; Willeit, P.; Mayr, U.;Prokopi, M.; Mayr, A.; Weger, S.; Oberhollenzer, F.; Bonora, E.;Shah, A.; Willeit, J.; Mayr, M. Plasma microRNA profiling revealsloss of endothelial miR-126 and other microRNAs in type 2diabetes. Circ Res, 2010, 107, 810-817.
62. Zhang, Y.; Liu, D.; Chen, X.; Li, J.; Li, L.; Bian, Z.; Sun, F.; Lu, J.;Yin, Y.; Cai, X.; Sun, Q.; Wang, K.; Ba, Y.; Wang, Q.; Wang, D.;Yang, J.; Liu, P.; Xu, T.; Yan, Q.; Zhang, J.; Zen, K.; Zhang, C.Y. Secreted monocytic miR-150 enhances targeted endothelial cellmigration. Mol. Cell., 2010, 39, 133-144.
63. Lanford, R.E.; Hildebrandt-Eriksen, E.S.; Petri, A.; Persson, R.;Lindow, M.; Munk, M.E.; Kauppinen, S.; Orum, H. Therapeuticsilencing of microRNA-122 in primates with chronic hepatitis Cvirus infection. Science, 2010, 327, 198-201.
64. Kay, C.D. The future of flavonoid research. Br. J. Nutr., 2010, 104Suppl 3, S91-S95.
65. Howard, B.V.; Kritchevsky, D. Phytochemicals and cardiovasculardisease. A statement for healthcare professionals from the American Heart Association. Circulation, 1997, 95, 2591-2593.
66. Peterson, J.; Dwyer, J.; Adlercreutz, H.; Scalbert, A.; Jacques, P.;McCullough, M.L. Dietary lignans: physiology and potential forcardiovascular disease risk reduction. Nutr. Rev., 2010, 68, 571-603.
67. Rimbach, G.; Boesch-Saadatmandi, C.; Frank, J.; Fuchs, D.;Wenzel, U.; Daniel, H.; Hall, W.L.; Weinberg, P.D. Dietaryisoflavones in the prevention of cardiovascular disease--amolecular perspective. Food Chem. Toxicol., 2008, 46, 1308-1319.
68. Williamson, G.; Clifford, M.N. Colonic metabolites of berrypolyphenols: the missing link to biological activity? Br. J. Nutr., 2010, 104 Suppl 3, S48-S66.
69. Hollman, P.C.; Katan, M.B. Health effects and bioavailability ofdietary flavonols. Free Radic. Res., 1999, 31 Suppl, S75-S80.
70. Gonzalez-Santiago, M.; Fonolla, J.; Lopez-Huertas, E. Humanabsorption of a supplement containing purified hydroxytyrosol, anatural antioxidant from olive oil, and evidence for its transientassociation with low-density lipoproteins. Pharmacol. Res., 2010, 61, 364-370.
71. Steinberg, D.; Witztum, J.L. Oxidized low-density lipoprotein andatherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2010, 30, 2311-2316.
72. Badimon, L.; Vilahur, G.; Padro, T. Nutraceuticals andatherosclerosis: human trials. Cardiovasc. Ther., 2010, 28, 202-215.